The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 01, 2022
Filed:
Oct. 18, 2019
Applicant:
Acceleron Pharma Inc., Cambridge, MA (US);
Inventor:
Kenneth M. Attie, Boston, MA (US);
Assignee:
ACCELERON PHARMA INC., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61P 17/02 (2006.01); A61P 7/06 (2006.01); C07K 14/475 (2006.01); A61K 47/68 (2017.01); C07K 14/71 (2006.01); C07K 19/00 (2006.01); C07K 14/715 (2006.01); A61K 38/00 (2006.01); A61K 38/18 (2006.01); A61K 45/06 (2006.01); A61K 31/16 (2006.01); A61K 31/17 (2006.01); A61K 31/4196 (2006.01); A61K 31/4422 (2006.01); A61K 38/45 (2006.01); C07K 16/22 (2006.01);
U.S. Cl.
CPC ...
A61K 38/179 (2013.01); A61K 38/1793 (2013.01); A61K 47/6811 (2017.08); A61P 7/06 (2018.01); A61P 17/02 (2018.01); C07K 14/475 (2013.01); A61K 31/16 (2013.01); A61K 31/17 (2013.01); A61K 31/4196 (2013.01); A61K 31/4422 (2013.01); A61K 38/00 (2013.01); A61K 38/1816 (2013.01); A61K 38/45 (2013.01); A61K 45/06 (2013.01); C07K 14/71 (2013.01); C07K 14/715 (2013.01); C07K 16/22 (2013.01); C07K 19/00 (2013.01); C07K 2317/31 (2013.01); C07K 2317/52 (2013.01); C07K 2317/76 (2013.01); C07K 2319/30 (2013.01); C07K 2319/31 (2013.01); C07K 2319/32 (2013.01); C07K 2319/90 (2013.01); C12Y 207/1103 (2013.01);
Abstract
The present disclosure provides compositions and methods for treating or preventing ulcers in subjects having low red blood cell levels and/or hemoglobin levels (e.g, anemia). In some embodiments, the compositions of the disclosure may be used to treat or prevent ulcers associated with anemia.